Kenvue Inc. (NYSE:KVUE) Shares Purchased by NorthRock Partners LLC

NorthRock Partners LLC raised its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 149.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,421 shares of the company’s stock after acquiring an additional 17,629 shares during the period. NorthRock Partners LLC’s holdings in Kenvue were worth $628,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in KVUE. Kiley Juergens Wealth Management LLC raised its holdings in Kenvue by 1.9% during the fourth quarter. Kiley Juergens Wealth Management LLC now owns 27,110 shares of the company’s stock worth $579,000 after purchasing an additional 500 shares in the last quarter. Principle Wealth Partners LLC increased its position in shares of Kenvue by 3.7% during the 4th quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company’s stock valued at $303,000 after purchasing an additional 500 shares during the period. White Pine Capital LLC raised its stake in shares of Kenvue by 1.0% in the 4th quarter. White Pine Capital LLC now owns 54,572 shares of the company’s stock worth $1,165,000 after buying an additional 542 shares in the last quarter. Deseret Mutual Benefit Administrators lifted its holdings in shares of Kenvue by 29.0% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company’s stock valued at $54,000 after buying an additional 568 shares during the period. Finally, SRS Capital Advisors Inc. boosted its stake in Kenvue by 67.4% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company’s stock valued at $30,000 after buying an additional 571 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on KVUE shares. Citigroup boosted their price target on shares of Kenvue from $22.00 to $24.50 and gave the stock a “neutral” rating in a research report on Friday, May 9th. Barclays lifted their price objective on shares of Kenvue from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday. Canaccord Genuity Group raised their target price on shares of Kenvue from $24.00 to $29.00 and gave the stock a “buy” rating in a report on Wednesday, March 5th. Piper Sandler lifted their price target on shares of Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a research report on Monday, February 24th. Finally, Redburn Atlantic assumed coverage on Kenvue in a research note on Thursday, April 10th. They set a “neutral” rating and a $23.50 price objective for the company. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Kenvue presently has an average rating of “Hold” and an average target price of $25.33.

Kenvue Price Performance

KVUE opened at $23.86 on Friday. The firm has a market capitalization of $45.78 billion, a P/E ratio of 45.02, a PEG ratio of 2.62 and a beta of 1.02. The stock has a fifty day moving average of $23.15 and a 200-day moving average of $22.58. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. The firm had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. During the same period last year, the company posted $0.28 EPS. The business’s quarterly revenue was down 3.9% compared to the same quarter last year. Equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a yield of 3.44%. The ex-dividend date is Wednesday, May 14th. Kenvue’s payout ratio is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.